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Objective: This study was to evaluate the efficacy of the hyarulonic acid (HA) bioab-
sorbable membrane combined use with both expanded-polytetrafluoroethylene
(ePTFE) and autologous pericardium for preventing postoperative pericardial adhe-
sions.
Methods: The HA bioresorbable surgical membrane (Seprafilm, Genzyme, Cam-
bridge, Mass) was used with either ePTFE or autologous pericardium in an experi-
mental pericardial adhesion model. Twenty-four beagle dogs were classified as
follows; Group A (n5 6): ePTFE only, Group B (n5 6): Seprafilm1 ePTFE, Group
C (n 5 6): autologous pericardium only, Group D (n 5 6): Seprafilm 1 autologous
pericardium. Pericardial adhesions were evaluated at necropsy at 4, 8, and 12 weeks.
The tenacity of adhesion was graded by macroscopic examination, and the adhesion
tissue thickness was analyzed microscopically with an image processing program.
The regeneration of mesothelial cells on neo-tissue fibrils were immunohistochemi-
cally studied.
Results: In groups B and D, the adhesions were significant lower compared with those
of control groups in the tenacity (Group A vs B: 2.56 0.55 vs 1.56 0.55, P, 0.05;
Group C vs D: 3.26 0.75 vs 0.336 0.52, P, 0.01) and the tissue thickness (Group A
vs B: 30.4 6 12.9 vs 10.3 6 4.42, P , 0.01; Group C vs D: 22.6 6 11.5 vs 4.96 6
4.87, P, 0.01). Immunohistochemically, a single layer of mesothelial cells were re-
generated on the surface of neo-tissue fibrils in HA treated groups.
Conclusion: The combined use of Seprafilm with either ePTFE or autologous pericar-
dium effectively reduced the formation of pericardial adhesion.
A
t the time of reoperation in cardiac surgery, injury to the heart, great vessels,
and any aorta–coronary bypass graft results in severe hemorrhage with
significant morbidity and mortality.1 In congenital heart disease, patients
with univentricular physiology undergo several surgical procedures during the first
years of life.2 Others, patients with right ventricle–pulmonary artery conduit, may
require reoperation for conduit stenosis or insufficiency later in life. Although the
number of patients was limited, reoperation is inevitable in adult cardiac surgery
for ischemic heart disease and valvular heart disease. Any reoperation in congenital
or adult cardiac surgery imposes an increased surgical risk onto the individual
patient.3 This increased risk is mostly caused by the occurrence of surgical adhesions.
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ETAbbreviations and Acronyms
ANOVA 5 analysis of variance
ePTFE 5 expanded polytetrafluoroethylene
HA 5 hyarulonic acid
NTF 5 neotissue fibrils
PLSD 5 protected least significant difference
This problem is especially serious in children because it is
technically difficult to establish extracorporeal circulation
by cannulating the femoral vessels.
Despite continuous research over the decades, an ideal
method to prevent postoperative pericardial adhesion for-
mation has not been found so far. Pericardial reconstruction
with expanded polytetrafluoroethylene (ePTFE) has demon-
strated more success4 but also has been reported to induce
severe constrictive pericardial adhesions.5,6 The natural bio-
polymer, hyarulonic acid (HA), reduces adhesion formation
in abdominal surgery.7-9 Recently, an acceptable clinical re-
sult of HA membrane for reduction of postoperative adhe-
sion in pediatric heart surgery was observed.10
In this study, we describe the use of the HA bioabsorbable
membrane combined with both ePTFE and autologous peri-
cardium in prevention of postoperative pericardial adhesion
in a canine model.
Material and Methods
Antiadhesive Membrane
The HA bioresorbable membrane (Seprafilm, Genzyme, Cam-
bridge, Mass), which was composed of sodium hyaluronate and car-
boxymethylcellulose, was used in this study. The size of the
membrane was approximately 5 3 5 cm. The membrane was
brought out from the holder and applied to the intended area.
Animal Preparation
The Animal Care and Use Committee of Tokyo Women’s Medical
University approved the use of the animals. All animals received hu-
man care in compliance with the ‘‘Principles of Laboratory Animal
Care’’ formulated by the National Society forMedical Research, and
the ‘‘Guide for the Care and Use of Laboratory Animals’’ published
by the National Institutes of Health (NIH publication 85-23, revised
in 1996).
Twenty-four beagle dogs weighing 9.1 to 12.5 kg were used in
this study. The animals were classified as follows by method of peri-
cardial reconstruction.
In group A (n5 6), an ePTFE (Gore-Tex pericardial membrane;
W. L. Gore&Associates, Inc, Flagstaff, Ariz) elliptic patch about 20
3 30 mm was used to cover the pericardial defect by continuous 6–
0 Prolene sutures (Ethicon, Inc, Somerville, NJ). In group B (n5 6),
after the HA bioresorbable membrane covered the epicardium,
ePTFE was placed to close the defect. In group C (n 5 6), the peri-
cardium was simply closed with no artificial materials. In group D,
the HA bioresorbable membrane covered the epicardium before
pericardial closure.The Journal of ThoraOperation
General anesthesia was induced by intravenous injection of sodium
pentobarbital (25 mg/kg) followed immediately by endotracheal
intubation; anesthesia was maintained by additional intravenous
injections of sodium pentobarbital (5 mg/kg). With the use of an
aseptic technique, a thoracotomy was performed through the fourth
or fifth intercostal space. Pericardium was opened longitudinally
about 3 cm in length, and the exposed epicardial surfaces of the right
ventricular outflow tract were desiccated and abraded for 3 minutes
with gauze. In groups A and B, the pericardium was resected about
the size of ePTFE patch. Then pericardium was closed according to
the method of pericardial reconstruction with nonabsorbable
monofilament fiber with blood contained in the intrapericardial
cavity. A thoracic drain was placed to evacuate the thoracic cavity,
and the chest was closed in 3 layers with nonabsorbable sutures.
Subsequently, after complete suction, the thoracic drain was
removed.
Macroscopic Evaluation
In each group, every 2 animals underwent rethoracotomy 4, 8, or 12
weeks after the initial procedure, respectively. Intrapericardial adhe-
sions were scored by an observer blinded to the experimental
groups, according to the severity of adhesion; 0, no adhesion; 1,
mild adhesion (easy to dissect manually); 2, moderate adhesion (co-
hesive and can be dissected manually); 3, severe adhesion (cohesive,
requires sharp dissection); 4, undissectable (bleeding occurred from
the heart).
Microscopic Evaluation
After macroscopic examination, the animals were humanely killed,
and both the myocardium of the right ventricular outflow tract and
the pericardial tissue were explanted en bloc. For the light
microscopic evaluation, the specimens were fixed in 10%
phosphate-buffered formalin and cut into segments containing
the adhesive parts. The suture line in the explanted tissue repre-
sents the zone of contact with the native pericardial tissue or the
ePTFE. If the corresponding piece of native pericardial tissue
was not adhesive to myocardium, it was also explanted. All the
specimens were embedded in paraffin. Each tissue was stained
with hematoxylin–eosin and Masson trichrome stain, and the
microscopic evaluation was performed to measure the extent of
fibrosis.
Immunohistochemical Analysis of Mesothelial Cells
Additional sections of the specimens were also stained with immu-
nohistochemical techniques by using monoclonal antibodies against
HBME-1 (DAKO Corporation, Carpinteria, Calif) to identify meso-
thelial cell.
Adhesion Tissue Thickness Analysis With Image
Processing Program
The neotissue fibrils (NTF), which consisted of dense collagen fiber,
could be distinguished microscopically from myocardium and adi-
pose tissue in Masson trichrome stain (Figure 1). The image of
each tissue of 100 magnification was analyzed with the National
Institutes of Health Image program (version 1.62; National Institutes
of Health, Springfield, Va), and the area of adhesion tissue was
calculated as the adhesion tissue thickness.cic and Cardiovascular Surgery c Volume 135, Number 4 851
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ETFigure 1. The adhesion tissue thickness
analysis. The neotissue fibrils, which
consist of dense collagenous fiber,
could be distinguished from myocar-
dium microscopically in Masson
trichrome stain. The image of each tis-
sue was analyzed by National Institutes
of Health image, and the area of
adhesion tissue was calculated. ePTFE,
Expanded polytetrafluoroethylene.Statistics
All statistical analyses were performed by SPSS for Windows,
version 11.5 (SPSS Inc, Chicago, Ill). All data are presented as
mean 6 SD. Normally distributed data were compared by the Stu-
dent t test and 1-way analysis of variance. The nonparametric
Mann–Whitney U test and Kruskal–Wallis test were conducted to
compare the difference if the data were not normal distribution.
The post hoc tests were conducted as multiple comparisons with
either the Fisher protected least significant difference (PLSD) test
or the Scheffe´ test according to the distribution of data.
Results
All animals tolerated the procedure with no apparent postop-
erative complications. Clinical follow-up over 3 months did
not reveal any abnormalities except for a superficial wound
infection. The HA significantly reduced the adhesion tenacityscore in groups B and D (P, .05 and P, .01, respectively,
byMann–WhitneyU test) compared with control groups, and
the adhesion tissue thickness was significantly lower in
groups B and D (P , .01 in both groups by the Student
t test) than in the control groups (Table 1).
Macroscopic Examination
In group A, the control animals, moderate-to-severe tena-
cious adhesions were observed between the epicardium
and the ePTFE patch, and the edges of the epicardium
were intimately adherent to both the pericardium and ePTFE
and extremely difficult to dissect out (Figure 2, A). In con-
trast, the adhesion formation in group B, the HA-treated
group, was extremely low. A smooth pericardium-like mem-
brane was observed and several fibrous strands were formed
between ePTFE and epicardium, which facilitated a quickFigure 2. Three months after the initial
operation, moderate-to-severe tena-
cious adhesions were observed be-
tween the epicardium and the ePTFE
patch in group A (A), whereas the adhe-
sion formation in group B was ex-
tremely low, with several fibrous
strands formed on the epicardial sur-
face (B). In group C, marked adhesion
formation, which was difficult to dis-
sect out, was observed in the pericar-
dial cavity (C). In group D, almost no
adhesion was formed in the pericardial
cavity, and the epicardium was almost
intact, which made the coronary
vessels clearly identifiable (D).
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ETand easy dissection between the epicardium and ePTFE (Fig-
ure 2, B).
In group C, marked adhesions between epicardium and
pericardium were observed, and the adhesions in this group
were so tenacious that the pericardial tissue could not be sep-
TABLE 1. Evaluation with adhesion tenacity scores and
adhesion tissue thickness
Groups
Duration to
planned death
Adhesion
tenacity score
Adhesion
tissue thickness
A (control) 4 wk 2 22.4
4 wk 3 34.5
8 wk 2 21.8
8 wk 3 28.5
12 wk 3 54.5
12 wk 2 20.9
Mean 6 SD 2.5 6 0.55 30.4 6 12.9
B (HA treated) 4 wk 2 6.38
4 wk 1 9.11
8 wk 2 17.4
8 wk 2 13.2
12 wk 1 5.65
12 wk 1 9.8
1.5* 6 0.55 10.3z 6 4.42
C (control) 4 wk 3 14.9
4 wk 4 34.1
8 wk 2 9.61
8 wk 3 26.5
12 wk 3 13.5
12 wk 4 9.8
3.2 6 0.75 22.6 6 11.5
D (HA treated) 4 wk 0 2.41
4 wk 0 1.11
8 wk 1 12.6
8 wk 0 2.45
12 wk 1 9.59
12 wk 0 1.62
0.3y 6 0.52 4.96z 6 4.87
SD, Standard deviation; HA, hyarulonic acid . *P, .05. yP, .01 versus con-
trol by Mann–Whitney U test. zP , .01 versus control by Student t test.arated from the heart without damaging the myocardial tissue
(Figure 2, C). As was observed in group B, the adhesion for-
mation in group D, the HA-treated group, was extremely low.
Almost no adhesion was formed in the pericardial cavity, and
the epicardium was almost intact, which made the coronary
vessels clearly identifiable (Figure 2, D).
There was a significant difference of the mean tenacity
score of adhesion in the studied groups (P , .05, by Krus-
kal–Wallis test), and group D showed a significantly lower
score of adhesion than other groups (D vs A, P , .01; D
vs B, P, .05; D vs C, P, .01; respectively, by the Scheffe´
test) (Figure 3, A).
Microscopic Examination
All specimens consisted of a mesothelium-like lining, NTF,
myocardium, and adipose tissue. In group A, a thick layer
of NTF that consisted of collagen fiber was observed between
ePTFE and epicardium. These findings were in direct agree-
ment with those observed at macroscopic examinations
(Figure 4, A). In group B, the surface of NTF on the ePTFE
sheet was covered with a mesothelium-like lining (Figure 4,
B1), under which there was a layer of fibrous tissue with
a population of fibroblast (Figure 4, B2). In group C, a mod-
erately thick layer of NTF was noted between the epicardium
and pericardium, and small arteries or blood capillaries had
developed in the NTF (Figure 4, C). In group D, a very
thin layer of NTF was formed on the surface of epicardium
(Figure 4, D1), and it was covered with a mesothelium-like
lining as was observed in group B (Figure 4, D2).
There was a significant difference in the mean adhesion
tissue thickness in the studied groups (P , .01, by 1-way
analysis of variance). Group D showed significantly less tis-
sue thickness than groups A and C (D vs A, P, .01; D vs C,
P, .01, respectively, by the Fisher PLSD test), whereas, the
difference between groups B and D was not statistically sig-
nificant (P 5 .097 by the Fisher PLSD test) (Figure 3, B).
Immunohistochemical Study
Group D showed a single layer of mesothelial cells lining the
whole surface of NTF on the epicardium (Figure 5, A). InFigure 3. Mean adhesion tenacity score
(A) and mean adhesion tissue thickness
(B). *P < .05, **P < .01, respectively, by
the Scheff test. yP < .01 by the Fisher
PLSD test.
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neotissue fibrils (NTF) was observed
between expanded polytetrafluoroethy-
lene (ePTFE) and epicardium (A). In
group B, the surface of NTF on ePTFE
sheet was covered with a mesothe-
lium-like lining (arrows) (B1, B2). In
group C, a moderately thick layer of
NTF with small arteries was noted be-
tween the epicardium and pericardium
(C). In contrast, a very thin layer of
NTF was formed on the surface of
epicardium in group D (D1). A meso-
thelium-like lining (arrows) was identi-
fied on the surface of NTF (D2). AT,
Adipose tissue; AT in PC, adipose tissue
in pericardium; Myo, myocardium; HE,
Hematoxylin–eosin stain; MT, Masson
trichrome stain.group B, several mesothelial cell linings on NTF were regen-
erated on the ePTFE patch in the same way as in group D
(Figure 5, B).
Discussion
Mechanism of Postoperative Adhesion Formation
Histologic examination of peritoneal tissue obtained from
animals undergoing abdominal surgical procedures indicates
that damage to the mesothelium caused by ischemia, trauma,
or infection is adhesiogenic.11 As regards pericardium, the
presence of both blood and serosal injury has been identified
as necessary for adhesion development.12 Leak and associ-
ates13 examined the temporal changes in an experimental
model of pericarditis with subsequent adhesion formation
and discussed the 4 steps of adhesion formation: (1) the exu-
dation of fluid, inflammatory cells, and fibrin (in 24 hours),
(2) desquamation of injured mesothelial cells with aggrega-
tion of inflammatory cells to the mesothelial surfaces and
fibrin deposition (in 72 hours), (3) fibrinolysis and collagen
deposition with the growth of new blood and lymphatic
vessels into new connective tissue (in a week), and (4)
development of focal adhesions (in 2 weeks).Current Reported Methods for Prevention of
Postoperative Adhesions
A large number of investigations for preventing postopera-
tive adhesions were conducted, but optimal methods to
prevent adhesions are not available at present.
1. PTFE. A survey was conducted among cardiac sur-
geons to gather information on experience with the
use of pericardial substitutes. The findings at reopera-
tion showed the experience with ePTFE pericardial
substitutes to be satisfactory.14 Loebe and associates15
described their clinical use of ePTFE surgical mem-
brane in congenital heart disease, finding its use for
pericardial closure in children to be safe for preventing
complications at reoperation.
2. Silicone. Several groups attempted to use silicone as
a pericardial substitute for prevention of adhesion.16,17
Laks, Hammond, and Geha18 reported their experi-
ence with silicone rubber as pericardial substitute in
both adult and pediatric cardiac operations. They con-
cluded that the silicone rubber greatly facilitated open-
ing of the sternum but did not have help to prevent
adhesion formation within the pericardium.Figure 5. Immunohistochemically stained
mesothelial cells. In group D, a single
layer of mesothelial cell lining (arrows)
on the whole surface of neotissue fibrils
(NTF) was observed (A). In group B, sev-
eral mesothelial cell linings (arrows) on
NTF were recognized in the same way
as groupD (B). ePTFE, Expanded polytetra-
fluoroethylene.
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venting pericardial adhesions with excellent results.5
In the clinical setting, however, bovine pericardium
used as pericardial substitute was reported to cause
several complications.19
4. Absorbable polymer. Several experimental studies
have been conducted to reduce postoperative adhesion
formation with biocompatible absorbable mem-
brane,20-22 but none of these materials has been
applied in the clinical setting so far.
5. Prevention of fibrinogenesis. In the pathogenesis of
adhesion formation, an imbalance between fibrin
deposition and fibrin dissolution is the key event.23
Pericardial adhesions were believed to form in conse-
quence of impaired pericardial fibrinolytic activity.
The several fibrinolytic agents were reported to reduce
postoperative pericardial adhesion in a rabbit model.
However, further work is required to assess their
safety in terms of bleeding or altered healing before
they are used clinically.24
6. HA biocompatible membrane. The efficacy of HA to
prevent postoperative adhesions was demonstrated
in various surgical fields involving cardiovascular sur-
gery. Pericardial tissue surfaces are known to posses
inherent fibrinolytic activity that is reduced after me-
sothelial damage has occurred,25 particularly when
cardiopulmonary bypass is used.26 Fibrinolytic activ-
ity in the pericardial cavity is resumed significantly by
the sixth day after injury.13 Until mesothelial healing
occurs, the presence of a nonreactive barrier that
blocks the contact between the damaged pericardial
surface and surrounding tissue could prevent signifi-
cant postoperative adhesion.
Benefit of Combined Use of HAWith Either ePTFE or
Autologous Pericardium
In the majority of patients with congenital heart disease,
autologous pericardium is excised to be used for surgical
corrections (eg, right ventricular outflow tract patch
enlargement, atrioventricular septal defect repair). Mean-
while, direct closure of the autologous pericardium is possi-
ble in a small number of young patients with single
ventricular physiology when they undergo either pulmonary
artery banding or bidirectional Glenn anastomosis. Although
the number of patients was limited, reoperation is inevitable
in adult cardiac surgery for ischemic heart disease and valvu-
lar heart disease where direct closure of autologous peri-
cardium is feasible. Considering results of prevention of
postoperative adhesion formation, combined use of HA
with ePTFE was a reasonable method in that both measures
were currently in clinical use and showed acceptable results.
Our results showed significant low tenacity scores of adhe-
sion in group D, whereas there was no statistically significant
difference between groups B andD as regards adhesion tissueThe Journal of Thothickness, which might support the beneficial effect of com-
bined use of HA with ePTFE.
HA biocompatible membrane becomes a gel in 24 to 48
hours after application to organ surfaces and stays
unabsorbed for approximately 7 days in the peritoneal cavity,
which results in a physical barrier against surrounding tissue
to prevent adhesion formation.7 The persistence time of HA
membrane in the pericardial space is unknown, although it
would partially prevent the aggregation of inflammatory cells
and fibrin deposition to the mesothelial surfaces, which
occurs in 72 hours after mesothelial injury according to
Leak’s theory.13 If the foreign material was used in the
pericardial space, inflammatory response would occur to
some extent, which results in the formation of NTF; how-
ever, the noncontacted area created by HA gel would prevent
the NTF overgrowth to form several cavities between the
foreign material and the epicardium. Additionally, use of
biocompatible material would contribute to preclude the
foreign body reaction seen with permanently implanted
devices.
In the HA-treated groups, we were surprised to find that
a single layer of mesothelial cells was regenerated on NTF,
which implies long-term effect against adhesion formation
in that mesothelial cells retain fibrinolytic function. The
HA was one of the major structural components of the
extracellular matrix. The extracellular matrix is known to
serve several functions in controlling cell behaviors, such
as adhesion, growth, proliferation, and migration.27 The
HA was reported to be involved in cell proliferation and
haptotaxis in mesothelial cell lineage.28 We speculated that
the HA had a beneficial effect on mesothelial cell migration,
adhesion, and proliferation on the surface of NTF.
Limitation of the Study
The experimental results could not be completely reproduc-
ible clinically because the median sternotomy model was
not used, the induction of adhesion in this study was limited,
cardiopulmonary bypass was not performed, bleeding was
minimal, crystalloid rinsing of the chest was not performed,
and the subjects were not cyanotic. In current cardiac surgery,
reoperations within a 3-month period are infrequent, and the
follow-up period of 3 months is short. Further experiments
with longer observation periods are necessary to elucidate
the issue.
Conclusions
In pericardial reconstruction with either ePTFE or autologous
pericardium, the HA biocompatible membrane significantly
reduced postoperative pericardial adhesion.
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